JAMA Network Home
Sign In
Research Letter

Demographic Data Supporting FDA Authorization of AI Devices for Alzheimer Disease and Related Dementias

JAMA 10.1001/jama.2025.12779

July 30, 2025 at 9:00 AM EDT

Read the full article

This cohort study examines the availability and representativeness of data supporting US Food and Drug Administration–authorized artificial intelligence and machine learning devices to treat Alzheimer disease and related dementias.

Corresponding Author: Ravi Gupta, MD, MSHP, Johns Hopkins University School of Medicine, 1830 E Monument St, Baltimore, MD 21287 (ravigupta@jhmi.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.12779?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=073025

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks